Early Phase 1 Migraine Trial, Recruiting NCT06016465 Sponsor: Texas Tech University Health Sciences Center, El Paso Condition: Migraine
Back to Migraine

Early Phase 1 Migraine Trial, Recruiting

NCT06016465
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with migraines that meet specific international medical guidelines (called ICHD-3 criteria)
  • After receiving a nerve block treatment, your headache pain dropped by at least 5 points on a pain scale, or your pain score afterwards was between 0 and 2 out of 10
  • Your nerve block was performed using a specific numbing medication called bupivacaine 0.5%

Who may not be able to join:

  • You have had a head injury or head trauma
  • There is a suspicion that your headache may be caused by another condition, such as a stroke, a known brain tumor, or glaucoma
  • Your headache is happening as part of a viral illness (such as the flu or a similar infection)
  • You take steroid medications on a long-term, ongoing basis
  • You have a known allergy to a medication called dexamethasone
  • You cannot be contacted by phone or text message for follow-up after the trial
  • You have gestational diabetes or any other type of diabetes that is not well controlled
  • You have a condition or take medication that weakens your immune system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Susan Watts, PhD., Texas Tech University Health Sciences Center, Department of Emergency Medicine

Phone: 915 215 4600

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Texas Tech University Health Sciences Center, El Paso
Registry
ClinicalTrials.gov
Start date
15 September 2023
Est. completion
30 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Recurrence of headache

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov